These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 8428096)

  • 1. Abdominal imaging.
    Stark DD; Fahlvik AK; Klaveness J
    J Magn Reson Imaging; 1993; 3(1):285-95. PubMed ID: 8428096
    [No Abstract]   [Full Text] [Related]  

  • 2. [Oral contrast media for magnetic resonance tomography of the abdomen. III. Initial patient research with gadolinium-DTPA].
    Claussen C; Kornmesser W; Laniado M; Kaminsky S; Hamm B; Felix R
    Rofo; 1988 Jun; 148(6):683-9. PubMed ID: 2837806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gadolinium-DTPA enhanced MRI in neonatal osteomyelitis of the cervical spine.
    Martijn A; van der Vliet AM; van Waarde WM; van Aalderen WM
    Br J Radiol; 1992 Aug; 65(776):720-2. PubMed ID: 1393402
    [No Abstract]   [Full Text] [Related]  

  • 4. Contrast-enhanced MR imaging of the female pelvis.
    Hricak H; Kim B
    J Magn Reson Imaging; 1993; 3(1):297-306. PubMed ID: 8428097
    [No Abstract]   [Full Text] [Related]  

  • 5. [Gadolinium-DTPA as an oral contrast medium for MR tomography of the abdomen].
    Krahe T; Dölken W; Lackner K; Houselog M; Habscheid W; Clauss W
    Rofo; 1990 Aug; 153(2):167-73. PubMed ID: 2168072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamic contrast-enhanced MR imaging of the upper abdomen: enhancement properties of gadobutrol, gadolinium-DTPA-polylysine, and gadolinium-DTPA-cascade-polymer.
    Adam G; Neuerburg J; Spüntrup E; Mühler A; Scherer K; Günther RW
    Magn Reson Med; 1994 Nov; 32(5):622-8. PubMed ID: 7808263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Oral contrast media for the magnetic resonance tomography of the abdomen. A clinical trial of the tolerance for gadolinium-DTPA].
    Kaminsky S; Laniado M; Gogoll M; Kornmesser W; Clauss W; Felix R
    Rofo; 1992 Jan; 156(1):17-23. PubMed ID: 1733470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical applications of gadolinium-DTPA in MRI.
    de Roos A; Doornbos J; Baleriaux D; Bloem HL; Falke TH
    Magn Reson Annu; 1988; ():113-45. PubMed ID: 3079294
    [No Abstract]   [Full Text] [Related]  

  • 9. [Oral contrast medium for magnetic resonance tomography of the abdomen. II. Phase I clinical testing of gadolinium-DTPA].
    Kornmesser W; Laniado M; Hamm B; Clauss W; Weinmann HJ; Schulz E; Wolf KJ; Felix R
    Rofo; 1987 Nov; 147(5):550-6. PubMed ID: 2825293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynamic imaging of contrast enhancement in brain tumors.
    Bullock PR; Mansfield P; Gowland P; Worthington BS; Firth JL
    Magn Reson Med; 1991 Jun; 19(2):293-8. PubMed ID: 1881318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Key to upper abdomen MRI imaging].
    Nogi A
    Nihon Hoshasen Gijutsu Gakkai Zasshi; 2006 Jan; 62(1):28-38. PubMed ID: 16485357
    [No Abstract]   [Full Text] [Related]  

  • 12. Giant extra-adrenal pheochromocytoma: magnetic resonance imaging with gadolinium-DTPA enhancement.
    Terk MR; de Verdier H; Colletti PM
    Magn Reson Imaging; 1993; 11(1):47-50. PubMed ID: 8423721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subtracted synthetic images in Gd-DTPA enhanced MR.
    Suto Y; Caner BE; Tamagawa Y; Matsuda T; Kimura I; Kimura H; Toyama T; Ishii Y
    J Comput Assist Tomogr; 1989; 13(5):925-8. PubMed ID: 2778158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Magnetic resonance imaging contrast agents. Design and physicochemical properties of gadodiamide.
    Chang CA
    Invest Radiol; 1993 Mar; 28 Suppl 1():S21-7. PubMed ID: 8486500
    [No Abstract]   [Full Text] [Related]  

  • 15. Contemporary and emerging technologies in abdominal magnetic resonance imaging.
    Liu PS; Hussain HK
    Semin Roentgenol; 2013 Jul; 48(3):203-13. PubMed ID: 23796371
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical applications of contrast agents in body imaging.
    Bydder GM
    Top Magn Reson Imaging; 1991 Mar; 3(2):74-84. PubMed ID: 2025434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gadolinium-DTPA enhanced MR imaging of intradural neurenteric cysts.
    Pierot L; Dormont D; Queslati S; Cornu P; Rivierez M; Bories J
    J Comput Assist Tomogr; 1988; 12(5):762-4. PubMed ID: 3170836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Value of contrast enhancement with Gd-DTPA in MRI of brain tumors. A comparison with X-ray CT].
    Tsuji T; Kishikawa T; Ikezaki K; Fujii K; Matsumoto S; Koga T
    Fukuoka Igaku Zasshi; 1987 Dec; 78(12):578-97. PubMed ID: 3447928
    [No Abstract]   [Full Text] [Related]  

  • 19. Contrast agents in magnetic resonance imaging.
    Roux E; De Broe L
    J Belge Radiol; 1988; 71(1):31-6. PubMed ID: 3372466
    [No Abstract]   [Full Text] [Related]  

  • 20. Formulation of radiographically detectable gastrointestinal contrast agents for magnetic resonance imaging: effects of a barium sulfate additive on MR contrast agent effectiveness.
    Rubin DL; Muller HH; Young SW
    Magn Reson Med; 1992 Jan; 23(1):154-65. PubMed ID: 1734177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.